tyndalized lactic bacteria + milk protein + lactic acid Vaginal tablets - 1 g
Country of origin
European Union
GMP approvals
Italy
Recommended use
Gynaecology
Product description
Vulvo-vaginal atrophy. Protection against pathogenic microbiotics such as Streptococci and Candida
Manufacturer #36950
European pharmaceutical company with experience in developing and commercializing specialty and generic Rx medicines for European and international markets. Oral solid, liquid, and injectable dosage forms cover key therapeutic areas. Engages in strategic licensing partnerships for product development and market expansion.
Manufacturer usually replies in 24 days